New Data on Esketamine Nasal Spray as Treatment for Adolescents Contemplating Suicide
December 12th 2023These important findings on esketamine nasal spray as a treatment for young individuals with suicidal ideation were presented at the ACNP 2023 Annual Meeting. We interviewed the vice president and head of neuropsychiatry clinical development at Johnson & Johnson Innovative Medicine to learn more.
The Rx Crisis: The Impact of Ongoing ADHD Medication Shortages
August 7th 2023According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.